Found: 7
Select item for more details and to access through your institution.
GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.629633
- By:
- Publication type:
- Article
Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.578963
- By:
- Publication type:
- Article
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.579868
- By:
- Publication type:
- Article
Prognostic value of DKK2 from the Dickkopf family in human breast cancer.
- Published in:
- International Journal of Oncology, 2018, v. 53, n. 6, p. 2555, doi. 10.3892/ijo.2018.4588
- By:
- Publication type:
- Article
RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.650499
- By:
- Publication type:
- Article
Bleomycin Suppresses the Proliferation and the Mobility of Human Gastric Cancer Cells Through the Smad Signaling Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 6, p. 1401, doi. 10.1159/000453192
- By:
- Publication type:
- Article